Oesophago-Gastric Cancer
作者： Alex M. Reece-Smith , Simon L. Parsons , Sue A. Watson
DOI: 10.1007/978-1-61779-615-9_8
关键词:
摘要: The continuing high incidence of oesophago-gastric cancer in Eastern countries along with the rising incidence, particularly adenocarcinomas, Western has led these cancers to become one leading causes cancer-related death globally.
springer.com
sci-hub.st 参考文章(178)
John E Park, Helen H Chen, Jane Winer, Keith A Houck, Napoleone Ferrara, None, Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Journal of Biological Chemistry. ,vol. 269, pp. 25646- 25654 ,(1994) , 10.1016/S0021-9258(18)47298-5
Suzuki T, Ishikawa T, Kobayashi M, Mai M, Ooi A, Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. American Journal of Pathology. ,vol. 151, pp. 761- 768 ,(1997)
B A Gusterson, R D Gelber, A Goldhirsch, K N Price, J Säve-Söderborgh, R Anbazhagan, J Styles, C M Rudenstam, R Golouh, R Reed, Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. Journal of Clinical Oncology. ,vol. 10, pp. 1049- 1056 ,(1992) , 10.1200/JCO.1992.10.7.1049
Heike Allgayer, Rudolf Babic, Klaus Uwe Gruetzner, Anwar Tarabichi, Friedrich Wilhelm Schildberg, Markus Maria Heiss, c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems Journal of Clinical Oncology. ,vol. 18, pp. 2201- 2209 ,(2000) , 10.1200/JCO.2000.18.11.2201
Classification of adenocarcinoma of the oesophagogastric junction British Journal of Surgery. ,vol. 85, pp. 1457- 1459 ,(2003) , 10.1046/J.1365-2168.1998.00940.X
Soji Ozawa, Masaki Kitajima, Yuko Kitagawa, Nobuyoshi Shimizu, Nobutoshi Ando, Masakazu Ueda, Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clinical Cancer Research. ,vol. 2, pp. 909- 914 ,(1996)
R.R. Tubbs, J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, T.M. Grogan, Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message Journal of Clinical Oncology. ,vol. 19, pp. 2714- 2721 ,(2001) , 10.1200/JCO.2001.19.10.2714
Nikolas H Stoecklein, Annika Siegmund, Peter Scheunemann, Andreas M Luebke, Andreas Erbersdobler, Pablo E Verde, Claus F Eisenberger, Matthias Peiper, Alexander Rehders, Jan Schulte am Esch, Wolfram Trudo Knoefel, Stefan B Hosch, Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker BMC Cancer. ,vol. 6, pp. 165- 165 ,(2006) , 10.1186/1471-2407-6-165
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Huiyan Zeng, Harold F. Dvorak, Debabrata Mukhopadhyay, Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways Journal of Biological Chemistry. ,vol. 276, pp. 26969- 26979 ,(2001) , 10.1074/JBC.M103213200